Table 10

Vital Signs

Vital Sign

Placebo Wk 0

Placebo Wk 8

A Wk. 0

A Wk. 8

B Wk. 0

B Wk. 8

C Wk. 0

C Wk. 8

Pulse Rate

80.3 ± 1.3

76.9 ± 1.1

79.1 ± 1.3

74.7 ± 0.9

80.7 ± 1.3

76.1 ± 1.2

78.6 ± 0.9

76.6 ± 0.9

Systolic BP

128 ± 1

130 ± 2

129 ± 2

130 ± 3

132 ± 2

129 ± 3 *

129 ± 1

128 ± 2

Diastolic BP

83 ± 1

86 ± 1

82 ± 1

82 ± 1

83 ± 1

82 ± 1

80 ± 1

80 ± 2

Respiration Rate

19.5 ± 0.7

19.9 ± 0.7

19.2 ± 0.6

18.9 ± 0.4

19.7 ± 0.7

19.4 ± 0.8

20.2 ± 0.5

18.5 ± 0.5 *

Data expressed as a mean ± sem. Units of measure were: Pulse rate (beats per min), systolic and diastolic blood pressure (mm Hg), respiration rate (breaths per minute). Group A = High dose sierrasil (n = 20), Group B = Low dose sierrasil (n = 21), Group C = Low dose sierrasil + cat's claw extract (n = 25), placebo n = 22. Pulse rate and respiration rate are given as the rate per minute and blood pressure is expressed in mm Hg. Using unpaired t test, the following descriptors describe a significant difference from baseline, *p < 0.05.

Miller et al. Journal of Inflammation 2005 2:11   doi:10.1186/1476-9255-2-11